MidWestOne Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MidWestOne Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,802	Closed	-$26.7K	–	275
2022 Q4	$26.7K	Sell	16,802 -3,666	-18%	-$305K	0.01%	233
2022 Q3	$1.27M	Buy	20,468 +8,281	+68%	+$579K	0.32%	69
2022 Q2	$972K	Sell	12,187 -275	-2%	-$26K	0.24%	96
2022 Q1	$1.31M	Buy	12,462 +2,049	+20%	+$200K	0.28%	84
2021 Q4	$1.12M	Buy	10,413 +4,726	+83%	+$516K	0.24%	108
2021 Q3	$623K	Buy	5,687 +183	+3%	+$19K	0.15%	142
2021 Q2	$515K	Buy	5,504 +830	+18%	+$76.4K	0.12%	154
2021 Q1	$430K	Buy	+4,674	New	+$394K	0.1%	156

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MidWestOne Financial Group's HZNP Position: Q1 2023 in Review

MidWestOne Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 16,802 shares — an estimated $26.7K sold.

MidWestOne Financial Group first reported a position in HZNP in Q1 2021 and held it in 8 quarters. The position peaked at $1.31M in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

MidWestOne Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
MidWestOne Financial Group sold 16,802 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $26.7K.
MidWestOne Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 8 quarters.
MidWestOne Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.31M in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on MidWestOne Financial Group's 13F filing for Q1 2023, filed 16 May 2023.